Antiphospholipid antibodies and thrombosis

Area of Science:

• Immunology
• Hematology
• Obstetrics & Gynecology

Background:

• Antiphospholipid antibodies (aPL) are autoantibodies associated with thrombosis and pregnancy morbidity.
• These antibodies target various phospholipid-binding proteins.
• Clinical manifestations include venous/arterial thrombosis, thrombocytopenia, and recurrent pregnancy loss.

Purpose of the Study:

• To review recent advances in aPL immunology and target antigens.
• To discuss mechanisms underlying thrombosis and thrombocytopenia.
• To highlight new diagnostic methods and therapeutic recommendations for aPL-associated syndromes.

Main Methods:

• Literature review of recent research on antiphospholipid antibodies.
• Synthesis of information on immunology, pathogenesis, diagnostics, and clinical manifestations.
• Analysis of current therapeutic strategies.

Main Results:

• Recent advances in understanding aPL immunology and target antigens.
• Elucidation of potential mechanisms for thrombosis and thrombocytopenia.
• Development of new laboratory identification methods for aPL.
• Comprehensive overview of clinical syndromes and treatment options.

Conclusions:

• Antiphospholipid antibodies represent a significant autoimmune concern with diverse clinical implications.
• Continued research is crucial for refining diagnostic accuracy and therapeutic efficacy.
• Multidisciplinary approaches are essential for managing patients with aPL-associated conditions.